Basic Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Feb 21, 2016; 22(7): 2314-2325
Published online Feb 21, 2016. doi: 10.3748/wjg.v22.i7.2314
Figure 1
Figure 1 Direct sequencing was used to validate novel pathological mutations. A: APC; B: MLH1; C: MSH2; D: PMS2; E: SMAD4; F: TP53.
Figure 2
Figure 2 Mutation distribution in colorectal cancer-related pathways. A: Relationship between the number of driver mutations (horizontal axis) and number of patients (vertical axis); B: Relationship between the six major pathways (horizontal axis) and the number of patient (vertical axis).